Rich Dad Poor Dad” author Robert Kiyosaki‘s decision to sell silver for Bitcoin at the start of the year has not aged well.
Contineum Therapeutics, Inc. (CTNM) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results